Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-18

Clinical Trial Update: Effect of Methylprednisolone on Orthostatic Intolerance and Heart Rate Variability in Hip-arthroplasty Patients [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update noting the completion of Phase 2 and Phase 3 studies evaluating methylprednisolone for orthostatic intolerance and heart rate variabilit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Osteoarthrosis | Phase 2, Phase 3 | Status: COMPLETED